The Age Of Agentic: A Complete Guide On Agents In Clinical Trials

Process and technology improvements trimmed roughly seven months from actual trial durations over five years, yet white space between trials grew by fourteen.

The argument here is that human-only effort has reached its ceiling and that agentic systems change the premise, not just the pace. It examines what separates a durable deployment from a stalled pilot: the ontology and connector layer beneath the agent, where autonomy belongs and where a human must decide, why build-versus-buy is really a question of validation, and why a vendor that must be taught Phase II from Phase III is a liability. It also covers early field results and a governance approach built for adaptive systems.

Explore the framework to see how the argument unfolds.